Recombinant FAAH antibody
-
- Target See all FAAH Antibodies
- FAAH (Fatty Acid Amide Hydrolase (FAAH))
- Antibody Type
- Recombinant Antibody
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Monoclonal
-
Conjugate
- This FAAH antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Cross-Reactivity
- Human, Mouse
- Purification
- Affinity-chromatography
- Immunogen
- A synthesized peptide derived from human FAAH1
- Clone
- 8G3
- Isotype
- IgG
- Top Product
- Discover our top product FAAH Primary Antibody
-
-
- Application Notes
- Recommended dilution: WB:1:500-1:5000, IHC:1:50-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C,-80 °C
- Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- FAAH (Fatty Acid Amide Hydrolase (FAAH))
- Alternative Name
- FAAH (FAAH Products)
- Background
-
Background: Degrades bioactive fatty acid amides like oleamide, the endogenous cannabinoid, anandamide and myristic amide to their corresponding acids, thereby serving to terminate the signaling functions of these molecules. Hydrolyzes polyunsaturated substrate anandamide preferentially as compared to monounsaturated substrates.
Aliases: Fatty-acid amide hydrolase 1 (EC 3.5.1.99) (Anandamide amidohydrolase 1) (Oleamide hydrolase 1), FAAH, FAAH1
- UniProt
- O00519
- Pathways
- Monocarboxylic Acid Catabolic Process
-